Showing results (31-40 of 203) with videos related to

Sort By:
Pageof 21
Blood|April 30, 2005
[18F]fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in aggressive lymphoma: an early prognostic tool for predicting patient outcomeCorinne Haioun, Emmanuel Itti, Alain Rahmouni, et al.
Hematology (Amsterdam, Netherlands)|September 18, 2012
Darbepoetin alfa administration in patients with non-Hodgkin lymphoma and chemotherapy-induced anemia receiving (±R) CHOPRuth Pettengell, Antonio Salar Silvestre, Matthias Schwenkglenks, et al.
European Radiology|March 10, 2015
Use of Model-Based Iterative Reconstruction (MBIR) in reduced-dose CT for routine follow-up of patients with malignant lymphoma: dose savings, image quality and phantom studyEdouard Hérin, François Gardavaud, Mélanie Chiaradia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2010
Improvement of early 18F-FDG PET interpretation in diffuse large B-cell lymphoma: importance of the reference backgroundEmmanuel Itti, Malik E Juweid, Corinne Haioun, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 19, 2008
Impact of rituximab and/or high-dose therapy with autotransplant at time of relapse in patients with follicular lymphoma: a GELA studyCatherine Sebban, Pauline Brice, Richard Delarue, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2013
A phase 2, multicentre, single-arm, open-label study to evaluate the safety and efficacy of single-agent lenalidomide (Revlimid) in subjects with relapsed or refractory peripheral T-cell non-Hodgkin lymphoma: the EXPECT trialFranck Morschhauser, Olivier Fitoussi, Corinne Haioun, et al.
Blood|July 13, 2006
Standard chemotherapy with interferon compared with CHOP followed by high-dose therapy with autologous stem cell transplantation in untreated patients with advanced follicular lymphoma: the GELF-94 randomized study from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)Catherine Sebban, Nicolas Mounier, Nicole Brousse, et al.
European Radiology|November 29, 2021
Optimization of whole-body 2-[18F]FDG-PET/MRI imaging protocol for the initial staging of patients with myelomaRobert Burns, Sébastien Mulé, Paul Blanc-Durand, et al.
The American Journal of Surgical Pathology|April 21, 2006
Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cellsJehan Dupuis, Karine Boye, Nadine Martin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 2013
Efficacy and toxicity of two schedules of bortezomib in patients with recurrent or refractory follicular lymphoma: a randomised phase II trial from the Groupe d'Etude des Lymphomes de l'Adulte (GELA)Vincent Ribrag, Hervé Tilly, Olivier Casasnovas, et al.
Pageof 21